Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00773U207 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 3
|
0% |
12/9/2025
Event 12/9/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 0% | ||
| FHMLSP, L.P. | 0% | ||
| FHMLSP, L.L.C. | 0% | ||
| Frazier Life Sciences X, L.P. | 0% | ||
| FHMLS X, L.P. | 0% | ||
| FHMLS X, L.L.C. | 0% | ||
| Frazier Life Sciences XI, L.P. | 0% | ||
| FHMLS XI, L.P. | 0% | ||
| FHMLS XI, L.L.C. | 0% | ||
| Frazier Life Sciences XII, L.P. | 0% | ||
| FHMLS XII, L.P. | 0% | ||
| FHMLS XII, L.L.C. | 0% | ||
| James N. Topper | 0% | ||
| Patrick J. Heron | 0% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 2
|
19.4% |
11/28/2025
Event 11/25/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 19.4% | ||
| FHMLSP, L.P. | 19.4% | ||
| FHMLSP, L.L.C. | 19.4% | ||
| Frazier Life Sciences X, L.P. | 1.0% | ||
| FHMLS X, L.P. | 1.0% | ||
| FHMLS X, L.L.C. | 1.0% | ||
| Frazier Life Sciences XI, L.P. | 2.3% | ||
| FHMLS XI, L.P. | 2.3% | ||
| FHMLS XI, L.L.C. | 2.3% | ||
| Frazier Life Sciences XII, L.P. | 2.4% | ||
| FHMLS XII, L.P. | 2.4% | ||
| FHMLS XII, L.L.C. | 2.4% | ||
| James N. Topper | 1.0% | ||
| Patrick J. Heron | 1.0% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 1
|
5.4% |
8/14/2025
Event 8/12/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 5.4% | ||
| FHMLSP, L.P. | 5.4% | ||
| FHMLSP, L.L.C. | 5.4% | ||
| Frazier Life Sciences Public Overage Fund, L.P. | 2.0% | ||
| FHMLSP Overage, L.P. | 2.0% | ||
| FHMLSP Overage, L.L.C. | 2.0% | ||
| Frazier Life Sciences X, L.P. | 0.6% | ||
| FHMLS X, L.P. | 0.6% | ||
| FHMLS X, L.L.C. | 0.6% | ||
| Frazier Life Sciences XI, L.P. | 1.3% | ||
| FHMLS XI, L.P. | 1.3% | ||
| FHMLS XI, L.L.C. | 1.3% | ||
| Frazier Life Sciences XII, L.P. | 0.6% | ||
| FHMLS XII, L.P. | 0.6% | ||
| FHMLS XII, L.L.C. | 0.6% | ||
| James N. Topper | 0.6% | ||
| Patrick J. Heron | 0.6% | ||
| Albert Cha | 0% | ||
| James Brush | 0% | ||
| Daniel Estes | 0% | ||
|
Franklin Resources, Inc.
13G/A
Amendment 1
|
0% |
8/5/2025
Event 6/30/2025
|
|
| Franklin Resources, Inc. | 0% | ||
| Charles B. Johnson | 0% | ||
| Rupert H. Johnson, Jr. | 0% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 2.0% |
7/16/2025
Event 6/30/2025
|
|
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
Amendment 2
|
0% |
2/14/2025
Event 12/31/2024
|
|
| Venrock Healthcare Capital Partners III, L.P. | 0% | ||
| VHCP Co-Investment Holdings III, LLC | 0% | ||
| Venrock Healthcare Capital Partners EG, L.P. | 0% | ||
| VHCP Management III, LLC | 0% | ||
| VHCP Management EG, LLC | 0% | ||
| Nimish Shah | 0% | ||
| Bong Y Koh | 0% | ||
| Rush Ryan Bradford 13G | 5.1% |
12/17/2024
Event 12/17/2024
|
|
|
Franklin Resources, Inc.
13G
|
8.5% |
10/31/2024
Event 9/30/2024
|
|
| Franklin Resources, Inc. | 8.5% | ||
| Charles B. Johnson | 0% | ||
| Rupert H. Johnson, Jr. | 0% | ||
| Franklin Advisers, Inc. | 8.5% |